Intravenous Glycoprotein IIb / IIIa Antagonists: Their Benefits, Problems and Future Developments
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1577-1585
Author(s):
Ronan Curtin
Oral GPIIb / IIIa Antagonists: What Went Wrong?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1587-1596
Author(s):
Dermot Cox
UR-3216: A New Generation Oral Platelet GPIIb / IIIa Antagonist
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1597-1601
Author(s):
Yasuhiro Aga, Kosuke Baba, Susan Tam, Takayuki Nakanishi, Kenji Yoneda, Jun-ichiro Kita and Hitoshi Ueno
Novel Integrin-Specific Targets for Anti-Platelet Therapies
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1603-1609
Author(s):
Aisling Robinson, Sarah O'Neill and Niamh Moran
Pharmacology of Nitric Oxide: Molecular Mechanisms and Therapeutic Strategies
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1667-1676
Author(s):
Regoli Domenico
Oxidative Stress in Essential Hypertension
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1695-1698
Author(s):
F. Portaluppi, B. Boari and R. Manfredini
Oxidative Stress During Myocardial Ischaemia and Heart Failure
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1699-1711
Author(s):
Roberto Ferrari, G. Guardigli, D. Mele, G. F. Percoco, C. Ceconi and S. Curello
Profiling the Shear Stress of Atherosclerosis; A Genomic View
Journal:
Current Genomics
Volume:
5
Page:
287-297
Author(s):
C. Stenson-Cox, V. Barron, B. P. Murphy, P. E. McHugh and T. Smith
Molecular Mechanisms, Proteinopathies and Therapeutic Strategies in Neurodegenerative Disorders
Journal:
Current Genomics
Volume:
5
Page:
327-346
Author(s):
L. K. Sengupta and S. Sengupta
Calcium Pumps of Plasma Membrane and Cell Interior
Journal:
Current Molecular Medicine
Volume:
4
Page:
323-335
Author(s):
Emanuel E. Strehler and Marek Treiman